Screener
ResMed RMD Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.
The source filing: ResMed’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:19 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000943819-26-000025
FAQ
- What is ResMed's equity method investments?
- ResMed (RMD) reported equity method investments of $78.47M in Q1 2026.
- How has ResMed's equity method investments changed year-over-year?
- ResMed's equity method investments increased by 20.0% year-over-year, from $65.38M to $78.47M.
- What is the long-term trend for ResMed's equity method investments?
- Over 4 years (2021 to 2025), ResMed's equity method investments has grown at a 29.0% compound annual growth rate (CAGR), from $23M to $63.64M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about ResMed's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude